Antiproliferative activity and synthesis of 8-prenylnaringenin derivatives by demethylation of 7-O-and 4’-O-substituted isoxanthohumols

Medicinal Chemistry Research

Volumn 21, Issue 12, 2012, Pages 4230-4238

  Anioł, Mirosław ^a   Świderska, Anna ^a   Stompor, Monika ^a   Żołnierczyk, Anna Katarzyna ^a  

^a ty of Environmental and Life Sciences ^*  (Poland)

Author keywords

Antiproliferative activity; Antitumor agents; CCRF CEM; Hop flavonoids; HT 29; MCF 7; Phytoestrogens

Indexed keywords

7 O PENTYL 8 PRENYLNARINGENIN; 7,4' DI O ALLYLISOXANTHOHUMOL; 8 PRENYLNARINGENIN; ALKYL GROUP; ALLYL COMPOUND; ANTINEOPLASTIC AGENT; ISOXANTHOHUMOL; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CCRF-CEM CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEMETHYLATION; DRUG SYNTHESIS; HT-29 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; MCF-7 CELL LINE; QUANTUM YIELD;

EID: 84855408797     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-011-9967-8     Document Type: Article

References (36)

1. Anioł M, Szymańska K, Żołnierczyk A (2008) An efficient synthesis of the phytoestrogen 8-prenylnaringenin from isoxanthohumol with magnesium iodide etherate. Tetrahedron 64:9544-9547
2. Bartoli G, Cupone G, Dalpozzo R, De Nino A, Maiuolo L, Marcantoni E, Procopio A (2001) Cerium-mediated deprotection of substituted allyl ethers. Synlett 12:1897-1900
3. Borrelli F, Ernst E (2010) Alternative and complementary therapies for the menopause. Maturitas 66:333-343
4. Böttner M (2008) Effects of long-term treatment with 8-prenylnaringenin and oral estradiol on the GH-IGF-1 axis and lipid metabolism in rats. J Endocrinol 198:395-401
5. Brunelli E, Minassi A, Appendino G, Moro L (2007) 8-prenylnaringenin, inhibits estrogen receptor-a mediated cell growth and induces apoptosis in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol 107:140-148
6. Brunelli E, Pinton G, Chianale F, Graziani A, Appendino G, Moro L (2009) 8-prenylnaringenin inhibits epidermal growth factorinduced MCF-7 breast cancer cell proliferation by targeting phosphatidylinositol-3-OH kinase activity. J Steroid Biochem Mol Biol 113:163-170
7. Cano A, Espinoza M, Ramos CH, Delgado G (2006) New prenylated flavanones from Esenbeckia berlandieri ssp. Acapulcensis. J Mexican Chem Soc 50:71-75
8. Chadwick LR, Paul GF, Farnsworth NR (2006) The pharmacognosy of Humulus lupulusL. (hops) with an emphasis on estrogenic properties. Phytomedicine 13:119-131
9. Colgate EC, Miranda CL, Stevens JF, Bray TM, Ho E (2007) Xanthohumol, a prenylflavonoid derived from hops induces apoptosis and inhibits NF-kappaB activation in prostate epithelial cells. Cancer Lett 246:201-209
10. Cos P, Maes L, Vlietinck A, Pieters L (2008) Plant-derived compounds for chemotherapy of human immunodeficiency virus (HIV) infection; an update (1998-2007). Planta Med 74:1323-1337
11. Delmulle L, Bellahcene A, Dhooge W, Comhaire F, Roelens F, Huvaere K, Heyerick A, Castronovo V, De Keukeleire D (2006) Anti-proliferative properties of prenylated flavonoids from hops (Humulus lupulus L.) in human prostate cancer cell lines. Phytomedicine 13:732-734
12. Drenzek JG, Seiler NL, Jaskula-Sztul R, Rausch MM, Rose SL (2011) Xanthohumol decreases Notch1 expression and cell growth by cell cycle arrest and induction of apoptosis in epithelial ovarian cancer cell lines. Gynecol Oncol 122:396-401
13. Faltermeier A, Massinger S, Schulmeyr J (2006) Process for preparing high-purity xanthohumol-containing powder and use thereof. Patentinhaber: NATECO@ GmbH and Co. KG German Patent Application DE 10 2006 018 988.4
14. Gester S, Metz P, Zierau O, Vollmer G (2001) An efficient synthesis of the potent phytoestrogens 8-prenylnaringenin and 6-(1, 1-dimethylallyl)naringenin by europium(III)-catalyzed Claisen rearrangement. Tetrahedron 57:1015-1018
15. Huempel M, Schleuning WD, Schaefer O, Isaksson P, Bohlmann R (2005) Use of 8-Prenylnaringenin for Hormone Replacement Therapy. European Patent Application EP 1524269 A1
16. Hyun JK, So-Hyun K, Bok YK, Ik-Soo L (2008) Microbial metabolism of the prenylated chalcone xanthohumol. Arch Pharm Res 31:1241-1246
17. Jacob C, Jamier V, Ba LA (2011) Redox active secondary metabolites. Curr Opin Chem Biol 2011(15):149-155
18. Jain AC, Gupta RC, Sarpal PD (1978) Synthesis of racemic 8-Cprenyl-600,600-dimethylpyrano(200,300:7, 6)naringenin. Tetrahedron 34:3563-3567
19. Marcinkowska E, Kutner A, Radzikowski C (1998) Cell differentiating and anti-proliferative activity of side-chain modified analogues of 1,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol 67:71-78
20. Metz P, Schwab P (2007) Preparation of (2S)-and (2R)-8-prenylnaringenin, used in e.G. pharmaceuticals, comprises reducing racemic mixture of 8-prenylnaringenin derivative with formic acid and base, separating non-transferred enantiomer and splitting acyl residue. German Patent Application DE 10 2006032500
21. Monteiro R, Faria A, Azevedo I, Calhau C (2007) Modulation of breast cancer cell survival by aromatase inhibiting hop (Humulus lupulus L.) flavonoids. J Steroid Biochem Mol Biol 105:124-130
22. Okano J, Fujise Y, Abe R, Imamoto R, Murawaki Y (2011) Chemoprevention against hepatocellular carcinoma. Clin J Gastroenterol 4:185-197
23. Oosterveld A, Voragen AGJ, Schols HA (2002) Characterization of hop pectins shows the presence of an arabinogalactan-protein. Carbohydr Polym 49:407-413
24. Overk C, Guo J, Chadwick L, Main M, Lantvit D, Minassi A, Appendino G, Pauli GF, van Breemen R, Farnsworth N, Boltona J (2008) In vivo estrogenic comparisons of Trifolium pratense (red clover), Humulus lupulus (Hops), and the Pure compounds isoxanthohumol and 8-prenylnaringenin. Chem-Biol Interact 176:30-39
25. Schaefer O, Bohlmann R, Schleuning WD, Schulze-Forster K, Huempel M (2005) Development of a radioimmunoassay for the quantitative determination of 8-prenylnaringenin in biological matrices. J Agric Food Chem 53:2881-2889
26. Siddiqui BS, Ali ST, Rasheed M, Kardar MN (2003) Chemical constituents of the flowers of Azadirachta indica. Helv Chim Acta 86:2787-2796
27. Skehan P, Storeng R, Scudiero D (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. JNatCancer Inst 82:1107-1112
28. Stevens JF, Page JE (2004) Xanthohumol and related prenylflavonoids from hops and beer to your good health. Phytohemistry 65:1317-1330
29. Stevens JF, Taylor AW, Nickerson GB, Ivancic M, Henning J, Haunold A, Deinzer ML (2000) Prenyl flavonoid variation in Humulus lupulus: distribution and taxonomic significance of xanthogalenol and 40-O-methylxanthohumol. Phytochemistry 53:759-775
30. 2O-NaI system. Tetrahedron Lett 40:7293-7294
31. Wesołowska O, Wiśniewski J, Środa K, Krawczenko A, Bielawska-Pohl A, Paprocka M, Duś D, Michalak K (2010a) 8-Prenylnaringenin is an inhibitor of multidrug resistance-associated transporters P-glycoprotein and MRP1. Eur J Pharmacol 644:32-40
32. Wesołowska O, Wiśniewski J, Środa K, Krawczenko A, Bielawska-Pohl A, Paprocka M, Duś D, Michalak K (2010b) 8-Prenylnaringenin is an inhibitor of multidrug resistance-associated transporters P-glycoprotein and MRP1. Eur J Pharmacol 644:32-40
33. Wilhelm H, Wessjohann LA (2006) An efficient synthesis of the phytoestrogen 8-prenylnaringenin from xanthohumol by a novel demethylation process. Tetrahedron 62:6961-6966
34. Yamaguchi S, Takai M, Hanazome I, Okada Y, Kawase Y (1987) Synthesis and structural studies of remirol. Bull Chem Soc Jpn 60:3603-3605
35. Yamaguchi S, Nedachi M, Yokoyama H, Hirai Y (1999) Regioselective demethylation of 2,6-dimethoxybenzaldehydes with magnesium iodide etherate. Tetrahedron Lett 40:7363-7365
36. Zanoli P, Zavatti M (2008) Pharmacognostic and pharmacological profile of Humulus lupulus L. J. Ethnopharmacol 116:383-396